Published in

J. epilepsy clin. neurophysiol., 2(13), p. 83-88

DOI: 10.1590/s1676-26492007000200009

Links

Tools

Export citation

Search in Google Scholar

Drug-induced gingival enlargement - Part II. Antiepileptic drugs: Not only phenytoin is involved

Journal article published in 2007 by Katia Lin, Laura M. F. F. Guilhoto ORCID, Elza Márcia Targas Yacubian
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown

Abstract

INTRODUCTION: Gingival enlargement is the term now used to describe medication-related gingival overgrowth or gingival hyperplasia, a common reactionary phenomenon that occurs with the use of several types of therapeutic agents, including antiepileptic drugs. This disorder has been recognized since 1939, shortly after the introduction of phenytoin. METHODS: Review of literature concerning etiology, pathogenesis and management of antiepileptic drug induced gingival enlargement. CONCLUSIONS: It is important that neurologists become aware of the potential etiologic agents of antiepileptic drug induced gingival enlargement and its characteristic features in order to be able to prevent, diagnose and successfully manage it.